Caribou Biosciences Company
Caribou Biosciences is an American startup, which is using Crispr-Cas9 technology in various domains, among which agriculture in order to create crops with high-protein profiles.
Investors
Technology:
Biotech
Industry:
AgTech
Headquarters:
Berkeley, California, United States
Founded Date:
2011-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
29
Total Funding:
$167,549,904
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-03-03
Last Funding Type:
Series C
Register and Claim Ownership